DEVELOPMENTAL CORE There is an urgent need for advances in neuroAIDS research that may lead to improved diagnostics and patient care. Such advances require an interdisciplinary approach with participation of investigators in basic, behavioral and clinical research. The major goal of the Comprehensive NeuroAIDS Center Cores (CNACC) is to facilitate interaction between basic science, behavioral research and clinical medicine by providing a mechanism of support for translational investigations through infrastructural and financial support, as well as mentorship. Toward this end, the Developmental Core will provide support for pilot investigations, progress evaluation, guidance, and mentorship. This core application describes the experience of the Core Leaders, the process to recruit and review innovative project applications, and the role the Core will play in mentorship of clinical and basic science faculty and trainees at various levels. It is anticipated that this core will play a pivotal role in enhancing and ensuring the success of neuroAIDS investigators, the advancement of neuroAIDS research and patient care, and the CNACC mission.

Public Health Relevance

To advance the field of neuroAIDS, there is an urgent need to establish new avenues of investigation that bridge the gap between discovery in basic science and promoting improvements in patient care. The Developmental Core will serve to bridge clinical and basic science by promoting pilot projects which are predicted to have high impact and at the same time promote the mentorship and training experiences for investigators at various levels

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH092177-04
Application #
8668163
Study Section
Special Emphasis Panel (ZMH1-ERB-F)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
4
Fiscal Year
2014
Total Cost
$159,164
Indirect Cost
$86,306
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Antell, Gregory C; Dampier, Will; Aiamkitsumrit, Benjamas et al. (2017) Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr Sequences. Int J Genomics 2017:4081585
Dampier, Will; Antell, Gregory C; Aiamkitsumrit, Benjamas et al. (2017) Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status. J Neurovirol 23:113-124
Sariyer, Rahsan; De-Simone, Francesca I; Donadoni, Martina et al. (2017) Alcohol-Mediated Missplicing of Mcl-1 Pre-mRNA is Involved in Neurotoxicity. Alcohol Clin Exp Res 41:1715-1724
Tahrir, Farzaneh G; Knezevic, Tijana; Gupta, Manish K et al. (2017) Evidence for the Role of BAG3 in Mitochondrial Quality Control in Cardiomyocytes. J Cell Physiol 232:797-805
Dampier, Will; Sullivan, Neil T; Chung, Cheng-Han et al. (2017) Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants. Sci Rep 7:14413
Sami Saribas, A; Cicalese, Stephanie; Ahooyi, Taha Mohseni et al. (2017) HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity. Cell Death Dis 8:e2542
Gupta, Manish K; Kaminski, Rafal; Mullen, Brian et al. (2017) HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy. Sci Rep 7:8572
Ahooyi, Taha Mohseni; Shekarabi, Masoud; Decoppet, Emilie A et al. (2017) Network Analysis of Hippocampal Neurons by Microelectrode Array in the Presence of HIV-1 Tat and Cocaine. J Cell Physiol :
O'Connor, E E; Jaillard, A; Renard, F et al. (2017) Reliability of White Matter Microstructural Changes in HIV Infection: Meta-Analysis and Confirmation. AJNR Am J Neuroradiol 38:1510-1519
Gannon, Patrick J; Akay-Espinoza, Cagla; Yee, Alan C et al. (2017) HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via ?-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. Am J Pathol 187:91-109

Showing the most recent 10 out of 115 publications